Taiwan Liposome Company Ltd ADR (TLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 529 | 502 | 523 | 482 | 0 |
| Gross Profit | 529 | 502 | 523 | 482 | N/A |
| Operating Expenses | 9,744 | 6,712 | 8,386 | 6,328 | 0 |
| Operating Income | -9,215 | -6,210 | -7,863 | -5,846 | N/A |
| Interest Expense | 76 | 183 | 39 | 25 | 0 |
| Other Income | -221 | -33 | 96 | 189 | 0 |
| Pre-tax Income | -9,512 | -6,426 | -7,806 | -5,682 | 0 |
| Income Tax | 17 | 9 | 8 | -6 | N/A |
| Net Income Continuous | -9,529 | -6,435 | -7,814 | -5,676 | N/A |
| Net Income | $-9,517 | $-6,435 | $-7,814 | $-5,688 | $N/A |
| EPS Basic Total Ops | -0.21 | -0.24 | -0.28 | -0.20 | N/A |
| EPS Basic Continuous Ops | -0.22 | -0.23 | -0.28 | -0.20 | N/A |
| EPS Diluted Total Ops | -0.21 | -0.24 | -0.28 | -0.20 | N/A |
| EPS Diluted Continuous Ops | -0.22 | -0.23 | -0.28 | -0.20 | N/A |
| EBITDA(a) | $-8,848 | $-5,851 | $-7,459 | $-5,425 | $N/A |